These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37117864)

  • 21. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.
    Kim HY; Kim CW; Park CH; Choi JY; Han K; Merchant AT; Park YM
    Hepatobiliary Pancreat Dis Int; 2016 Feb; 15(1):39-47. PubMed ID: 26818542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of sarcopenia identifies a special group of lean NAFLD in middle-aged and older people.
    Zhu X; Huang Q; Ma S; Chen L; Wu Q; Wu L; Ma H; Li X; Li Q; Aleteng Q; Hu Y; He W; Gao J; Lin H; Tang H; Gao X; Xia M
    Hepatol Int; 2023 Apr; 17(2):313-325. PubMed ID: 36327053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease.
    Petta S; Ciminnisi S; Di Marco V; Cabibi D; Cammà C; Licata A; Marchesini G; Craxì A
    Aliment Pharmacol Ther; 2017 Feb; 45(4):510-518. PubMed ID: 28028821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.
    Cabrera D; Ruiz A; Cabello-Verrugio C; Brandan E; Estrada L; Pizarro M; Solis N; Torres J; Barrera F; Arrese M
    Dig Dis Sci; 2016 Nov; 61(11):3190-3198. PubMed ID: 27572941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study.
    Lee HJ; Lee DC; Kim CO
    Front Endocrinol (Lausanne); 2021; 12():599339. PubMed ID: 33868162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
    Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease.
    Guo W; Zhao X; Miao M; Liang X; Li X; Qin P; Lu J; Zhu W; Wu J; Zhu C; Xu N; Zhang Q
    Front Nutr; 2022; 9():883015. PubMed ID: 35558748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
    Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
    Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restoring skeletal muscle mass as an independent determinant of liver fat deposition improvement in MAFLD.
    Zhou T; Ye J; Luo L; Wang W; Feng S; Dong Z; Zhuo S; Zhong B
    Skelet Muscle; 2023 Dec; 13(1):23. PubMed ID: 38115119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.
    Seo DH; Lee YH; Park SW; Choi YJ; Huh BW; Lee E; Huh KB; Kim SH; Cha BS
    Diabetes Metab; 2020 Oct; 46(5):362-369. PubMed ID: 31689496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations between muscle mass, strength, and performance and non-alcoholic fatty liver disease.
    Rigor J; Vasconcelos R; Lopes R; Moreira T; Barata P; Martins-Mendes D
    Minerva Gastroenterol (Torino); 2023 Sep; 69(3):374-381. PubMed ID: 35343663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease.
    Chung GE; Oh S; Ahn DW; Kim SH; Jung YJ; Kim JW; Kim BG; Lee KL; Jeong JB
    Sci Rep; 2023 Mar; 13(1):3628. PubMed ID: 36869158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.
    Shida T; Akiyama K; Oh S; Sawai A; Isobe T; Okamoto Y; Ishige K; Mizokami Y; Yamagata K; Onizawa K; Tanaka H; Iijima H; Shoda J
    J Gastroenterol; 2018 Apr; 53(4):535-547. PubMed ID: 28791501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy.
    Mikolasevic I; Domislovic V; Krznaric-Zrnic I; Krznaric Z; Virovic-Jukic L; Stojsavljevic S; Grgurevic I; Milic S; Vukoja I; Puz P; Aralica M; Hauser G
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208576
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of skeletal muscle mass evaluating methods on severity of metabolic associated fatty liver disease in non-elderly adults.
    Zhou T; Ye J; Lin Y; Wang W; Feng S; Zhuo S; Zhong B
    Br J Nutr; 2023 Oct; 130(8):1373-1384. PubMed ID: 36896599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA.
    Wijarnpreecha K; Kim D; Raymond P; Scribani M; Ahmed A
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1121-1128. PubMed ID: 30888971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease.
    Chung GE; Kim MJ; Yim JY; Kim JS; Yoon JW
    J Obes Metab Syndr; 2019 Jun; 28(2):129-138. PubMed ID: 31294345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of Serum Vitamin D Level with Sarcopenia, Non-Alcoholic Fatty Liver Disease (NAFLD), and Sarcopenia in NAFLD Among People Aged 50 Years and Older: The Korea National Health and Nutrition Examination Survey IV-V.
    Hong J; Shin WK; Lee JW; Lee SY; Kim Y
    Metab Syndr Relat Disord; 2022 May; 20(4):210-218. PubMed ID: 35100057
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography.
    Kim HS; Lee J; Kim EH; Lee MJ; Bae IY; Lee WJ; Park JY; Kim HK; Jung CH
    Diabetes Metab J; 2023 Jan; 47(1):104-117. PubMed ID: 36727165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.